Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys and Ribavirin for Relapsed HCV Genotype 2 or 3
NCT00641654Phase 4Terminated
- Sponsor
- University of Gothenburg
- Start
- Jan 2007
- Primary completion
- Dec 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a in hepatitis C (HCV) (3 arms), sponsored by University of Gothenburg. Primary endpoint: Sustained Viral Response. Started Jan 2007; status: terminated.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00641654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641654.